Hypha group composition having hepatitis B treatment activity, and preparation method thereof

A composition and active technology, applied in the field of preparation of the active mycelial group composition, can solve the problems of recurrence of liver disease, rampant hepatitis B virus, etc., and achieve the effects of regulating the endocrine system and the nervous system, delaying renal failure, and improving memory.

Inactive Publication Date: 2017-07-14
及长城
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But it is only a virus inhibitory effect, so it must be taken for a long time. If the hepatitis B virus continues to replicate quickly using cccDNA as a template after the drug is stopped, a large number of new hepatitis B viruses will become rampant again, causing liver disease recurrence
At present, there is a lack of a pure green natural bioactive mycelium health product that can treat hepatitis B without any hormone additives

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0116] A kind of active mycelium group combination that has treatment hepatitis B of the present invention, by weight percentage is made up of cypress mycelium 30%, wild ganoderma lucidum mycelium 20%, cordyceps sinensis mycelium 7%, frondosa frondosa mycelium 7%, 5% Yunzhi mycelium, 5% black boletus mycelium, 5% smooth mushroom mycelium, 5% chicken fir mycelium, 4% white fungus mycelium, 4% shiitake mushroom mycelium, matsutake mushroom Composition of 4% silk, 4% Coprinus comatus mycelium, and 3% black Gastrodia elata powder.

Embodiment 2

[0118] A kind of active mycelium group combination that has treatment hepatitis B of the present invention, by weight percentage is made up of cypress mycelium 26%, wild ganoderma lucidum mycelium 24%, cordyceps sinensis mycelium 7%, frondosa frondosa mycelium 7%, 6% Yunzhi mycelium, 6% black boletus mycelium, 4% mycelium of shiitake mushroom, 4% of chicken fir mycelium, 5% of white fungus mycelium, 5% of shiitake mushroom mycelium, matsutake mushroom Composition of 3% silk, 3% Coprinus comatus mycelium, and 3% black Gastrodia elata powder.

Embodiment 3

[0120] A kind of active mycelia combination with the treatment of hepatitis B of the present invention, by weight percentage is made up of cypress mycelium 25%, wild ganoderma lucidum mycelium 20%, cordyceps sinensis mycelium 6%, grifola frondosa mycelium 6%, 7% versicolor mycelium, 7% black boletus mycelium, 7% mycelium of shiitake mushroom, 7% of chicken fir mycelium, 5% of white fungus mycelium, 5% of shiitake mushroom mycelium, matsutake mushroom Composition of 3% silk, 2% Coprinus comatus mycelium, and 3% black Gastrodia elata powder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a hypha group composition having hepatitis B treatment activity, and a preparation method thereof, wherein the hypha group composition comprises, by weight, 25-30% of cypress mycelium, 20-24% of wild ganoderma lucidum mycelium, 5-7% of cordyceps sinensis mycelium, 5-7% of Grifola frondosus mycelium, 4-6% of Coriolus versicolor mycelium, 4-6% of Boletus aereus mycelium, 4-6% of pholiota nameko mycelium, 4-6% of Collybia albuminosa mycelium, 3-5% of white tremella mycelium, 3-5% of mushroom mycelium, 3-5% of Tricholoma matsutake mycelium, 3-5% of Coprinus comatus mycelium, and 2-3% of Gastrodia elata f.glauca. The product of the present invention can treat hepatitis B and is suitable for patients with hepatitis B.

Description

technical field [0001] The invention relates to an active mycelium composition for treating hepatitis B, and also relates to a preparation method of the active mycelium composition. Background technique [0002] All antiviral drugs currently on the market are ineffective against the original template of hepatitis B virus replication, and some drugs can only inhibit the replication of the virus after long-term use, and can significantly reduce the virus in the body. But it is only a virus inhibitory effect, so it must be taken for a long time. If the drug is stopped, the hepatitis B virus will continue to replicate quickly using cccDNA as a template. As a result, a large number of new hepatitis B viruses will become rampant again, causing liver disease recurrence. At present, there is a lack of a pure green natural bioactive mycelia health product that has the ability to treat hepatitis B and does not have any hormone additives. Contents of the invention [0003] The pur...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8988A61P1/16A61P31/20
CPCA61K9/16A61K9/20A61K9/48A61K36/06A61K36/068A61K36/07A61K36/074A61K36/14A61K36/888A61K36/8969A61K36/8988A61K2300/00
Inventor 及长城
Owner 及长城
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap